Talk:David Lucchino

COI Editor wants to improve page

Hello editors,

David Lucchino is a paid client of mine. I did not create his page or edit it previously. I seek to update this page to add some new activities he is involved in. I am seeking help from the volunteer community to review my proposed changes and if they pass muster, to add them to the page.

Meanwhile, I am going to make some minor edits to improve the page, such as by eliminating some typos and adding some references to existing text to better support the article.

JeffreyKrasner (talk) 18:50, 5 September 2019 (UTC)

COI editor is seeking help to improve a page

Hello User:Dormskirk, User:Keith D, User:Doc James, User:Barbara (WVS)

My name is Jeff and I am a paid editor. David Lucchino is one of my clients. I believe his page is in need of updating for new information and organization. Because you have each edited medical/biotech pages, I would really appreciate your help with improving this page. I have pasted below my suggested edits and would appreciate any feedback you may have.JeffreyKrasner (talk) 19:33, 19 September 2019 (UTC)

Project Onramp

In January 2019, Lucchino announced the formation of Project Onramp, a program that matches low-income students attending four-year colleges in Massachusetts with paid internships at local biotechnology companies.

The program, formed in collaboration with MassBio, the Massachusetts Life Sciences Center, Life Science Cares and Bottom Line, is intended to give disadvantaged students their start in life science careers, which is often difficult because companies do not publicize their summer internship programs.

Project Onramp was developed to help students who are not enrolled in elite schools like MIT and Harvard get a start in the life sciences industry. Industry would benefit because life sciences companies often have longstanding problems with a lack of diversity in their workforces.

In May 2019, Project Onramp announced it had matched 50 Massachusetts students with internships at life sciences companies.

COI editor requests help with edit

Hello. My name is Jeffrey and I am being paid by David Lucchino of Frequency Therapeutics to improve and update his page. My goal is to always be transparent and adhere to Wikipedia's policies and criteria. My user page does disclose this fact as well. I will be making a series of edit requests as the page has gotten significantly outdated.

I would like to request first a slight revision to the infobox. The current infobox lists Mr. Lucchino’s title with Frequency as “co-founder.” He is currently co-founder, president and CEO. So I would like to add “president and CEO” to his titles. The reason for the edit is to make the infobox accurate.

LIST OF PROPOSED CHANGES

Current text=	Replace with
title = Co-founder, Frequency Therapeutics	title = Co-founder, president and CEO, Frequency Therapeutics

Thank you for your time and attention to reviewing my request. I welcome feedback if something needs to be corrected. JeffreyKrasner (talk) 19:42, 17 August 2020 (UTC)

Hello, I made the request above more than a week ago. It is a reasonable request to improve the accuracy of the article. I haven't heard anything from any other editors, so I am going to implement this edit. If anyone has any objections or comments, please reach out to me. Thanks JeffreyKrasner (talk) 19:12, 26 August 2020 (UTC)

COI editor requests help with edit

Hello. My name is Jeffrey and I am being paid by David Lucchino of Frequency Therapeutics to improve and update his page. My goal is to always be transparent and adhere to Wikipedia's policies and criteria. My user page does disclose this fact as well. I will be making a series of edit requests as the page has gotten significantly outdated.

I would like to request first a slight revision of the first paragraph of the article. The reason for the edit is that, by adding a short description of the company’s industry niche, readers will have a more precise idea of the type of work the company does.

LIST OF PROPOSED CHANGES

Current text=

Replace with

David L. Lucchino is an American entrepreneur known for his work in the biotechnology and medical technology sectors. He is the co-founder and CEO of Frequency Therapeutics. Frequency is working on a treatment to reverse hearing loss, as well as treatments for other conditions based on a unique approach to regenerative medicine.

David L. Lucchino is a life sciences CEO and American entrepreneur known for his work in the biotechnology and medical technology sectors. Currently he is co-founder, president and CEO of Frequency Therapeutics (Nasdaq: FREQ), a clinical-stage biotechnology company developing a novel approach to regenerative medicine to create and commercialize therapeutics for degenerative conditions including hearing loss and multiple sclerosis. as well as treatments for other conditions, based on a unique approach to regenerative medicine.

Thank you for your time and attention to reviewing my request. I welcome feedback if something needs to be corrected. JeffreyKrasner (talk) 19:35, 26 August 2020 (UTC)

COI editor seeks input from the volunteer community

Hello all,

As noted above, I am a paid consultant to David Lucchino. I have been making several changes to his page using the COI template, to update the content and better reflect Lucchino's career. I haven't received any response, and I'm going to go ahead and make these changes, as I feel they improve the article, and are all supported by sources endorsed by Wikipedia's guidelines. I'm going to continue to work on this article so it is accurate and up-to-date. I would appreciate feedback from the volunteer community. I will also reach out directly to some volunteer editors who have worked on this page in the past.JeffreyKrasner (talk) 21:12, 3 September 2020 (UTC)

COI editor requests help with edit

Hello,

As noted above, I am an editor paid by Frequency Therapeutics. I am working to improve this page, with careful attention to Wikipedia standards and with appropriate references.

I would like to update the "Activities" section of the page, as David Lucchino's activities outside of Frequency Therapeutics have changed and the current text is no longer accurate. For instance, Lucchino is no longer on the Lipella Pharmaceuticals board of directors, and Caregroup is no longer active as an organization.

The reason for the edit is to delete out-of-date information and replace it with current information that is accurate.JeffreyKrasner (talk) 21:14, 23 September 2020 (UTC)

LIST OF PROPOSED CHANGES

Current text

Replace with

In March 2018, Lucchino began a two-year term as chairman of the Massachusetts Biotechnology Council.[20] Lucchino earlier was an elected member of the Board of Directors of the Massachusetts Biotechnology Council. He is a Trustee of Mt. Auburn Hospital, a 200-bed Harvard Medical School facility. He also serves on the Audit Committee for CareGroup: the parent organization of Mt. Auburn, Beth Israel Deaconess Medical Center and The New England Baptist Hospital.[21] In 2013, Lucchino joined the board of the Multiple Myeloma Research Foundation.[22] He was a member of the Board of Directors of the Advanced Medical Technology Association (AdvaMed), the national trade association representing the US medical device industry, from 2010 to 2013. He also serves as a director of Lipella Pharmaceuticals Inc.[23]

Lucchino served a two-year term as chairman of the Board of Directors of the Massachusetts Biotechnology Council from 2018-2020.[19] He is a member of the College of Fellows of the American Institute for Medical and Biological Engineering and was appointed by Massachusetts Governor Charlie Baker to the Commonwealth’s Science, Technology, Engineering and Math Advisory Council. He also serves as a trustee of Mt. Auburn Hospital, a Harvard Medical School facility; a member of the board of directors of the Multiple Myeloma Research Foundation; and a member of the Board of Advisors of Life Science Cares.

User:JeffreyKrasner requested that I take a look at his proposed edits and offer my thoughts. See his request here.

My thoughts on the proposed edits: I would maintain citation 20 (Business Journals) to support the two-year term as chairman of the board of directors of the MA Biotech Council. The second sentence about him being a Fellow at the American Institute for medical and Biological Engineering and being on the STEM Advisory Council needs a source. To support the final sentence better, I'd encourage you to find a third-party source discussing him appointment to the boards rather than just the links to the board's pages. In my opinion, these sentences are written in a neutral manner, so they shouldn't violate WP:NPOV. I invite other editors to weigh in with their thoughts. VentureKit (talk) 18:53, 24 September 2020 (UTC)

References

COI Request Response

Hi @JeffreyKrasner:, thank you for requesting an edit and declaring your conflict of interest. I have added a banner at the top declaring your conflict. Reading through the comments on this page, I noticed that you added your requested edits to the article when you did not receive a response after a week. This is strongly discouraged as outlined in Wikipedia:Paid-contribution disclosure. Even if you do not receive a response after a week, you should not add the information yourself. As outlined in the request edit banner, there is a severe backlog of requests and it is important that editors remain patient.

I have done a copy-edit of the entire article. I removed all claims because this is a biography of a living person and it is important that all the information is properly cited. This includes information in the infobox, his personal life, and various sentences throughout the article. I removed promotional language and information about the companies he worked at as the article should focus on what he has done, not what has happened at the companies. I also removed information about Project OnRamp as the Boston Globe article doesn't state that Lucchino had a role in creating this organisation, only that he participates in it. I also reformatted the information so that it was chronological instead of reverse-chronological.

If I missed a suggested change above, or if you would like to suggest more changes, please follow the instructions on Template:Request edit/Instructions. Happy editing! Z1720 (talk) 19:05, 22 November 2020 (UTC)